Ecstasy - MDMA and other ring-substituted amphetamines
31 December 2000
| Publication
Overview
Given the sustained high level of interest in ecstasy and recent findings relating to neurotoxicity, it was considered timely to undertake a specific review of the health effects of ecstasy. The primary focus of this review is 3,4-methylenedioxymethamphetamine (MDMA). However, some consideration is given to structurally related ring-substituted amphetamines, particularly those that are used or sold as ecstasy, either intentionally or through manufacturing errors.
Editors
World Health Organization
Number of pages
96
Reference numbers
WHO Reference Number: WHO/MSD/MSB/01.3
Copyright
World Health Organization